Boric acid, zinc sulphate
Sold as Special eye, Iris eye, I-kleer
Every registration of this product has been cancelled.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 3
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pandora Pharmaceuticals (Pty) Ltd*Cancelled | Special eye | drops | H1116 | Not determined | None |
| Gr Pharmaceuticals (1967) (Pty) LtdCancelled | Iris eye | drops | H1232 | Not determined | None |
| The Premier Pharmaceutical Co LtdCancelled | I-kleer | Not stated | H1238 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Special eye drops EACH 15 mL CONTAINS BORIC ACID A 0,327 g ZINC SULPHATE A 0,02085 g | Drops | H1116 | Cancelled | Not determined | None |
| Iris eye drops EACH 100 mL CONTAINS BORIC ACID A 2,0 g ZINC SULPHATE A 0,20 g | Drops | H1232 | Cancelled | Not determined | None |
| I-kleer EACH 15 ml CONTAINS BORIC ACID A 0,33 g ZINC SULPHATE A 0,0075 g | Not listed | H1238 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.